Literature DB >> 27158081

Ex-vivo liver perfusion for organ preservation: Recent advances in the field.

A S Barbas1, N Goldaracena2, M J Dib2, M Selzner2.   

Abstract

Liver transplantation is the optimal treatment for end-stage liver disease but is limited by the severe shortage of donor organs. This shortage has prompted increased utilization of marginal grafts from DCD and extended criteria donors, which poorly tolerate cold storage in comparison to standard criteria grafts. Ex-vivo liver perfusion (EVLP) technology has emerged as a potential alternative to cold storage for organ preservation, but there is no consensus regarding the optimal temperature or conditions for EVLP. Herein, we review recent advances in both pre-clinical and clinical studies, organized by perfusion temperature (hypothermic, subnormothermic, normothermic).
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27158081     DOI: 10.1016/j.trre.2016.03.002

Source DB:  PubMed          Journal:  Transplant Rev (Orlando)        ISSN: 0955-470X            Impact factor:   3.943


  8 in total

Review 1.  The promise of organ and tissue preservation to transform medicine.

Authors:  Sebastian Giwa; Jedediah K Lewis; Luis Alvarez; Robert Langer; Alvin E Roth; George M Church; James F Markmann; David H Sachs; Anil Chandraker; Jason A Wertheim; Martine Rothblatt; Edward S Boyden; Elling Eidbo; W P Andrew Lee; Bohdan Pomahac; Gerald Brandacher; David M Weinstock; Gloria Elliott; David Nelson; Jason P Acker; Korkut Uygun; Boris Schmalz; Brad P Weegman; Alessandro Tocchio; Greg M Fahy; Kenneth B Storey; Boris Rubinsky; John Bischof; Janet A W Elliott; Teresa K Woodruff; G John Morris; Utkan Demirci; Kelvin G M Brockbank; Erik J Woods; Robert N Ben; John G Baust; Dayong Gao; Barry Fuller; Yoed Rabin; David C Kravitz; Michael J Taylor; Mehmet Toner
Journal:  Nat Biotechnol       Date:  2017-06-07       Impact factor: 54.908

Review 2.  Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches.

Authors:  Gonzalo Sapisochin; Jordi Bruix
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-01-05       Impact factor: 46.802

Review 3.  Proteasome and Organs Ischemia-Reperfusion Injury.

Authors:  Joan Oliva
Journal:  Int J Mol Sci       Date:  2017-12-30       Impact factor: 5.923

4.  Prolongation of allograft survival by passenger donor regulatory T cells.

Authors:  Ines G Harper; Olivera Gjorgjimajkoska; Jacqueline H Y Siu; Jasvir Parmar; Arend Mulder; Frans H J Claas; Sarah A Hosgood; Michael L Nicholson; Reza Motallebzadeh; Gavin J Pettigrew
Journal:  Am J Transplant       Date:  2019-02-05       Impact factor: 8.086

5.  Pharmacological Activating Transcription Factor 6 Activation Is Beneficial for Liver Retrieval With ex vivo Normothermic Mechanical Perfusion From Cardiac Dead Donor Rats.

Authors:  Nuo Cheng; Ji-Hua Shi; Yang Jin; Yuan-Bin Shi; Xu-Dong Liu; Hua-Peng Zhang; Sheng-Li Cao; Han Yang; Wen-Zhi Guo; Shui-Jun Zhang
Journal:  Front Surg       Date:  2021-06-18

6.  Haemoadsorption reduces the inflammatory response and improves blood flow during ex vivo renal perfusion in an experimental model.

Authors:  Sarah A Hosgood; Tom Moore; Theresa Kleverlaan; Tom Adams; Michael L Nicholson
Journal:  J Transl Med       Date:  2017-10-25       Impact factor: 5.531

7.  The ultrastructural characteristics of porcine hepatocytes donated after cardiac death and preserved with warm machine perfusion preservation.

Authors:  Hiroki Bochimoto; Naoto Matsuno; Yo Ishihara; Tatsuya Shonaka; Daisuke Koga; Yoshiki Hira; Yuji Nishikawa; Hiroyuki Furukawa; Tsuyoshi Watanabe
Journal:  PLoS One       Date:  2017-10-12       Impact factor: 3.240

8.  Mild hypothermia during the reperfusion phase protects mitochondrial bioenergetics against ischemia-reperfusion injury in an animal model of ex-vivo liver transplantation-an experimental study.

Authors:  Rui Miguel Martins; João Soeiro Teodoro; Emanuel Furtado; Rui Caetano Oliveira; José Guilherme Tralhão; Anabela Pinto Rolo; Carlos Marques Palmeira
Journal:  Int J Med Sci       Date:  2019-09-07       Impact factor: 3.738

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.